Largest pharmaceuticals by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 61 pharmaceuticals ranked by earnings, at PLN 107.7B, ahead of Eli Lilly (PLN 82.9B) and Merck & Co (PLN 73.3B). Figures as of 18 Nov 2026, 14:10 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonPLN 107.7B
- Median
- PLN 237M
- Combined market value
- PLN 20.72T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | PLN 107.7B | PLN 2.69T | PLN 1,119.48 | 1.36% down | 38% up | ||
| 2 | Eli LillyLLY · Health Care | PLN 82.9B | PLN 5.06T | PLN 5,685.98 | 1.13% down | 35% up | ||
| 3 | Merck & CoMRK · Health Care | PLN 73.3B | PLN 1.42T | PLN 575.89 | 0.75% down | 51% up | ||
| 4 | Novo NordiskNVO · Health Care | PLN 61.1B | PLN 720.5B | PLN 163.48 | 2.16% down | 17% down | ||
| 5 | NovartisNVS · Health Care | PLN 56.2B | PLN 1.21T | PLN 639.19 | 0.67% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | PLN 41.1B | PLN 1.14T | PLN 732.14 | 0.95% down | 2% up | ||
| 7 | SanofiSNY · Health Care | PLN 34.8B | PLN 458.4B | PLN 190.92 | 1.78% down | 4% down | ||
| 8 | PfizerPFE · Health Care | PLN 31.2B | PLN 651.8B | PLN 114.36 | 1.35% down | 14% up | ||
| 9 | GSKGSK · Health Care | PLN 30.5B | PLN 396.5B | PLN 197.79 | 2.32% down | 6% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | PLN 28.3B | PLN 503.7B | PLN 246.43 | 2.51% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | PLN 26.2B | PLN 728.5B | PLN 420.60 | 2.55% down | 17% down | ||
| 12 | Regeneron PharmaceuticalsREGN · Health Care | PLN 18.1B | PLN 398B | PLN 3,847.13 | 0.56% up | 36% up | ||
| 13 | AbbVieABBV · Health Care | PLN 17B | PLN 2.08T | PLN 1,176.20 | 0.59% down | 26% up | ||
| 14 | Vertex PharmaceuticalsVRTX · Health Care | PLN 15.9B | PLN 544B | PLN 2,145.77 | 0.67% down | 27% up | ||
| 15 | ZoetisZTS · Health Care | PLN 10.7B | PLN 136.2B | PLN 335.32 | 1.08% down | 29% down | ||
| 16 | Teva Pharmaceutical IndustriesTEVA · Health Care | PLN 5.7B | PLN 199.8B | PLN 171.20 | 0.12% up | 74% up | ||
| 17 | United TherapeuticsUTHR · Health Care | PLN 5.4B | PLN 99.9B | PLN 2,346.21 | 0.64% down | 23% up | ||
| 18 | GenmabGMAB · Health Care | PLN 3.9B | PLN 128.7B | PLN 208.71 | 0.76% up | 70% up | ||
| 19 | Royalty PharmaRPRX · Health Care | PLN 3.1B | PLN 158.6B | PLN 275.87 | 0.23% up | 78% up | ||
| 20 | PTC TherapeuticsPTCT · Health Care | PLN 2.7B | PLN 20.3B | PLN 242.45 | 1.00% down | 20% down | ||
| 21 | Dr. Reddy's LaboratoriesRDY · Health Care | PLN 1.8B | PLN 49.5B | PLN 59.41 | 0.61% up | 5% up | ||
| 22 | TG TherapeuticsTGTX · Health Care | PLN 1.8B | PLN 38.1B | PLN 251.89 | 0.08% down | 107% up | ||
| 23 | GrifolsGRFS · Health Care | PLN 1.8B | PLN 23.6B | PLN 34.66 | 1.15% down | 1% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | PLN 1.4B | PLN 45.5B | PLN 235.02 | 0.90% up | 11% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | PLN 1.3B | PLN 84.2B | PLN 628.63 | 2.02% down | 66% down | ||
| 26 | BeOne MedicinesONC · Health Care | PLN 1.2B | PLN 189.6B | PLN 1,659.98 | 0.48% up | 17% up | ||
| 27 | AlkermesALKS · Health Care | PLN 970.7M | PLN 30.7B | PLN 182.56 | 2.32% down | 58% up | ||
| 28 | Ligand PharmaceuticalsLGND · Health Care | PLN 499.9M | PLN 23.6B | PLN 1,180.18 | 2.62% down | 43% up | ||
| 29 | Corcept TherapeuticsCORT · Health Care | PLN 400.3M | PLN 30.8B | PLN 281.46 | 1.23% up | 8% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | PLN 289.4M | PLN 29.6B | PLN 84.83 | 0.52% down | 83% up | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | PLN 237M | PLN 30B | PLN 382.04 | 0.93% up | 126% up | ||
| 32 | Arrowhead PharmaceuticalsARWR · Health Care | -PLN 6.6M | PLN 24.4B | PLN 172.68 | 2.76% down | 10% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | -PLN 93.8M | PLN 24.1B | PLN 369.34 | 0.40% up | 31% up | ||
| 34 | Travere TherapeuticsTVTX · Health Care | -PLN 102.6M | PLN 19.7B | PLN 205.26 | 2.82% up | 44% up | ||
| 35 | VeradermicsMANE · Health Care | -PLN 281.2M | PLN 21.3B | PLN 504.67 | 1.88% down | 233% up | ||
| 36 | Belite BioBLTE · Health Care | -PLN 311.7M | PLN 25.7B | PLN 633.53 | 2.98% down | 31% up | ||
| 37 | Oruka TherapeuticsORKA · Health Care | -PLN 423.5M | PLN 26.2B | PLN 386.90 | 2.94% down | 241% up | ||
| 38 | ErascaERAS · Health Care | -PLN 500.3M | PLN 19.6B | PLN 55.79 | 8.07% down | 403% up | ||
| 39 | Protagonist TherapeuticsPTGX · Health Care | -PLN 522.8M | PLN 32.7B | PLN 500.77 | 0.13% down | 46% up | ||
| 40 | Spyre TherapeuticsSYRE · Health Care | -PLN 623.4M | PLN 35.8B | PLN 376.82 | 5.60% down | 286% up | ||
| 41 | Dianthus TherapeuticsDNTH · Health Care | -PLN 652.1M | PLN 19.7B | PLN 349.38 | 2.87% down | 113% up | ||
| 42 | Edgewise TherapeuticsEWTX · Health Care | -PLN 674M | PLN 18.5B | PLN 168.87 | 3.75% down | 88% up | ||
| 43 | Axsome TherapeuticsAXSM · Health Care | -PLN 735.8M | PLN 28.7B | PLN 546.08 | 0.77% down | 7% down | ||
| 44 | Definium TherapeuticsDFTX · Health Care | -PLN 738.3M | PLN 16.2B | PLN 118.01 | 2.59% down | 169% up | ||
| 45 | Rhythm PharmaceuticalsRYTM · Health Care | -PLN 789.5M | PLN 32.5B | PLN 468.40 | 8.49% up | 13% up | ||
| 46 | Elanco Animal HealthELAN · Health Care | -PLN 931.9M | PLN 51.9B | PLN 103.83 | 2.12% down | 20% up | ||
| 47 | Ascendis PharmaASND · Health Care | -PLN 1B | PLN 71.5B | PLN 1,089.32 | 0.20% down | 28% up | ||
| 48 | Madrigal PharmaceuticalsMDGL · Health Care | -PLN 1.2B | PLN 39.4B | PLN 1,695.05 | 0.46% down | 24% down | ||
| 49 | Legend BiotechLEGN · Health Care | -PLN 1.2B | PLN 12.6B | PLN 64.71 | 0.75% up | 42% down | ||
| 50 | Roivant SciencesROIV · Health Care | -PLN 1.2B | PLN 112.7B | PLN 155.49 | 0.26% up | 90% up | ||
| 51 | Praxis Precision MedicinesPRAX · Health Care | -PLN 1.2B | PLN 34.3B | PLN 1,225.37 | 1.68% down | 61% up | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -PLN 1.3B | PLN 19.5B | PLN 111.87 | 1.49% up | 20% down | ||
| 53 | Jazz PharmaceuticalsJAZZ · Health Care | -PLN 1.4B | PLN 62.1B | PLN 966.88 | 0.39% up | 37% up | ||
| 54 | ABIVAXABVX · Health Care | -PLN 1.5B | PLN 28.9B | PLN 329.78 | 1.81% down | 27% down | ||
| 55 | Ionis PharmaceuticalsIONS · Health Care | -PLN 1.5B | PLN 18B | PLN 108.29 | 3.75% down | 64% down | ||
| 56 | BridgeBio PharmaBBIO · Health Care | -PLN 2.9B | PLN 60.1B | PLN 308.49 | 0.72% down | 17% up | ||
| 57 | CytokineticsCYTK · Health Care | -PLN 3.2B | PLN 28.9B | PLN 207.47 | 2.86% down | 20% down | ||
| 58 | Takeda PharmaceuticalTAK · Health Care | -PLN 3.8B | PLN 277.7B | PLN 86.92 | 0.23% up | 54% up | ||
| 59 | Summit TherapeuticsSMMT · Health Care | -PLN 4.3B | PLN 34.3B | PLN 42.86 | 9.73% down | 36% down | ||
| 60 | InsmedINSM · Health Care | -PLN 5.1B | PLN 107.4B | PLN 489.49 | 0.83% down | 40% down | ||
| 61 | ViatrisVTRS · Health Care | -PLN 14.1B | PLN 94.2B | PLN 82.14 | 1.40% down | 96% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0168 PLN).
Questions and answers
Which pharmaceuticals rank first by earnings?
Johnson & Johnson (PLN 107.7B), Eli Lilly (PLN 82.9B) and Merck & Co (PLN 73.3B) are the top three of the 61 pharmaceuticals ranked by earnings as of 18 Nov 2026, 14:10 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by earnings.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by earnings have a combined market value of PLN 20.72T as of 18 Nov 2026, 14:10 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceuticals by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.